T. Rowe Price Investment Management, Inc. Revolution Medicines, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 4,689,298 shares of RVMD stock, worth $165 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
4,689,298
Previous 1,673,429
180.22%
Holding current value
$165 Million
Previous $59.2 Million
191.55%
% of portfolio
0.11%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding RVMD
# of Institutions
331Shares Held
195MCall Options Held
908KPut Options Held
723K-
Vanguard Group Inc Valley Forge, PA15.8MShares$556 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.3MShares$505 Million2.37% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$473 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$373 Million0.2% of portfolio
-
Wellington Management Group LLP Boston, MA10.3MShares$362 Million0.07% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.09B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...